114 related articles for article (PubMed ID: 8683323)
1. Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanoma.
Magnani P; Paganelli G; Modorati G; Zito F; Songini C; Sudati F; Koch P; Maecke HR; Brancato R; Siccardi AG; Fazio F
J Nucl Med; 1996 Jun; 37(6):967-71. PubMed ID: 8683323
[TBL] [Abstract][Full Text] [Related]
2. Immunoscintigraphy with three step monoclonal pretargeting technique in diagnosis of uveal melanoma: preliminary results.
Modorati G; Brancato R; Paganelli G; Magnani P; Pavoni R; Fazio F
Br J Ophthalmol; 1994 Jan; 78(1):19-23. PubMed ID: 8110692
[TBL] [Abstract][Full Text] [Related]
3. The clinical role of immunoscintigraphy for the detection of ocular melanoma.
Schaling DF; Pauwels EK
Q J Nucl Med; 1996 Dec; 40(4):335-40. PubMed ID: 9050338
[TBL] [Abstract][Full Text] [Related]
4. MRI, antibody-guided scintigraphy, and glucose metabolism in uveal melanoma.
Lucignani G; Paganelli G; Modorati G; Pieralli S; Rizzo G; Magnani P; Colombo F; Zito F; Landoni C; Scotti G
J Comput Assist Tomogr; 1992; 16(1):77-83. PubMed ID: 1729312
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoscintigraphy in patients with early stage cutaneous malignant melanoma.
Blend MJ; Hyun H; Patel B; Sullivan K; Salk D
J Nucl Med; 1996 Feb; 37(2):252-7. PubMed ID: 8667055
[TBL] [Abstract][Full Text] [Related]
6. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
[TBL] [Abstract][Full Text] [Related]
7. Ocular radioimmunoscintigraphy: sensitivity and practical considerations.
Bomanji J; Nimmon CC; Hungerford JL; Solanki K; Granowska M; Britton KE
J Nucl Med; 1988 Jun; 29(6):1031-7. PubMed ID: 3373313
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoscintigraphy with melanoma-associated monoclonal antibody fragments in choroidal melanoma.
Schaling DF; van Kroonenburgh MJ; Borsje RA; Camps JA; Kakebeeke-Kemme HM; Oosterhuis JA; Pauwels EK
Graefes Arch Clin Exp Ophthalmol; 1989; 227(3):291-4. PubMed ID: 2500385
[TBL] [Abstract][Full Text] [Related]
9. Possibilities and limitations of radioimmunoscintigraphy and conventional diagnostic modalities in choroidal melanoma.
Schaling DF; Oosterhuis JA; Jager MJ; Kakebeeke-Kemme H; Pauwels EK
Br J Ophthalmol; 1994 Apr; 78(4):244-8. PubMed ID: 8199106
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunoscintigraphy in patients with ocular melanoma.
Sergieva SB; Virtcheva-Genkova A
Clin Nucl Med; 1997 Jan; 22(1):25-9. PubMed ID: 8993869
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA
Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020
[TBL] [Abstract][Full Text] [Related]
12. [Immunoscintigraphy in the diagnosis of choroid melanoma].
Calbiani B; Bontempelli C; Bonelli P; Franchini D; Bosi M; Pescatori A; Mammarella E; Ugolotti G
Radiol Med; 1990; 79(1-2):92-5. PubMed ID: 2315526
[TBL] [Abstract][Full Text] [Related]
13. Three-step tumor pre-targeting in lung cancer immunoscintigraphy.
Dosio F; Magnani P; Paganelli G; Samuel A; Chiesa G; Fazio F
J Nucl Biol Med (1991); 1993 Dec; 37(4):228-32. PubMed ID: 8172965
[TBL] [Abstract][Full Text] [Related]
14. [Values and limitations of radioimmunoscintigraphy with MoAb 225-28S in the diagnosis of posterior uveal melanoma].
Cavazza S; Tassoni A; Abbati A
J Fr Ophtalmol; 1992; 15(6-7):395-9. PubMed ID: 1294595
[TBL] [Abstract][Full Text] [Related]
15. Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy.
Cardillo TM; Karacay H; Goldenberg DM; Yeldell D; Chang CH; Modrak DE; Sharkey RM; Gold DV
Clin Cancer Res; 2004 May; 10(10):3552-61. PubMed ID: 15161715
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments.
Bomanji J; Hungerford JL; Granowska M; Britton KE
Br J Ophthalmol; 1987 Sep; 71(9):651-8. PubMed ID: 2822079
[TBL] [Abstract][Full Text] [Related]
17. [Immunoscintigraphy results in the comparison of ocular with cutaneous melanoma].
Löffler KU; Bräutigam P; Simon J; Althauser SR; Moser E; Witschel H
Ophthalmologe; 1994 Aug; 91(4):529-32. PubMed ID: 7950129
[TBL] [Abstract][Full Text] [Related]
18. Pretargeting of carcinomas with the avidin-biotin system.
Paganelli G; Magnani P; Fazio F
Int J Biol Markers; 1993; 8(3):155-9. PubMed ID: 8277207
[TBL] [Abstract][Full Text] [Related]
19. Imaging posterior uveal melanomas.
Rennie I
Br J Ophthalmol; 1994 Apr; 78(4):241. PubMed ID: 8199104
[No Abstract] [Full Text] [Related]
20. [Radioimmunoimaging of lymphoma in mice with a two-step pretargeting strategy using biotinyled CD45 monoclonal antibody and (188)Re-avidin].
Li G; Zheng W; Huang B; DU L; Qi Y; Huang K; Zhang H
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(8):1175-9. PubMed ID: 26277517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
